Finnrick - Ensuring a Safer and More Transparent Supply Chain
Laicuinuo LCN

Laicuinuo LCN

Tirzepatide

Finnrick tested 6 samples of Tirzepatide (GLP-1 and GIP agonist) from Laicuinuo LCN between 30 Sep 2025 and 6 Dec 2025. Test scores average over 6, no score below 5, and at least 6 tests warrant a confident Finnrick Rating of B (Good).

Finnrick Rating™
Laicuinuo LCN
Tirzepatide
Tested 6 Samples
Last test 6 Dec 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Tirzepatide tests from top-rated vendors:

All Tirzepatide tests from Laicuinuo LCN

Samples are tested in commercial labs

Tests Count

6

Scores

AVG8.0MIN5.2MAX10.0

Last

6 Dec 2025

First

30 Sep 2025
Quantity
Test DateCertificate
Test Score
Label
Batch
TestedDifferencePurityBatch IDContainerTested AtSent By
6 Dec 2025View6.320mg(no batch claim)34.6mg+73.0%99.95%Oct 2, 2025White Label / Silver Crimp / Violet CapLab EPublic
24 Oct 2025View7.130mg(no batch claim)32.09mg+7.0%99.80%(no batch ID)No Label / Silver Crimp / Pink Cap Lab GPublic
24 Oct 2025View5.25mg
6.4mg
4.98mg-22.1%99.60%2025.7.15(no data)Lab GPublic
23 Oct 2025View10.030mg(no batch claim)30.6mg+2.0%99.95%Sep 15, 2025No Label / Silver Crimp / Pink Cap Lab EPublic
3 Oct 2025View9.810mg(no batch claim)10mg99.82%July 15, 2025White Label / Silver Crimp / Yellow Cap Lab EPublic
30 Sep 2025View9.530mg
30.6mg
29.8mg-2.7%99.93%2025.01.15No Label / Silver Crimp / Violet Cap Lab EPublic